Share Price and Basic Stock Data
Last Updated: January 24, 2026, 3:56 pm
| PEG Ratio | -1.52 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Finolex Industries Ltd operates primarily in the plastics sector, focusing on pipes and fittings. As of the latest reporting, the company recorded a market capitalization of ₹10,752 Cr and a share price of ₹173. The revenue trend demonstrates a fluctuating performance over the past few quarters. For instance, sales stood at ₹941 Cr in September 2022, peaked at ₹1,179 Cr in June 2023, and subsequently declined to ₹883 Cr in September 2023. Despite this decline, the trailing twelve months (TTM) revenue is reported at ₹4,075 Cr. Yearly figures show a slight decline from ₹4,397 Cr in March 2023 to ₹4,317 Cr in March 2024, indicating challenges in maintaining consistent growth. The company has a robust shareholding base with 2,45,505 shareholders, reflecting a broad interest in its operations. Overall, the revenue fluctuations suggest a competitive landscape that may be affecting sales performance, typical of the cyclical nature of the plastics industry.
Profitability and Efficiency Metrics
Finolex Industries’ profitability metrics reveal a mixed performance. The reported net profit for the trailing twelve months is ₹437 Cr, translating to an earnings per share (EPS) of ₹7.04. The operating profit margin (OPM) was recorded at 15% for the latest quarter, although it has shown variability, reaching a high of 19% in March 2023, reflecting the challenges in cost management. The return on equity (ROE) stood at 6.76%, while the return on capital employed (ROCE) was reported at 8.77%, both of which are relatively low compared to industry benchmarks. Furthermore, the interest coverage ratio (ICR) is notably strong at 24.37x, indicating that the company comfortably meets its interest obligations. However, the cash conversion cycle (CCC) at 80 days could pose liquidity challenges, especially in a sector where cash flow management is crucial for sustaining operations.
Balance Sheet Strength and Financial Ratios
Finolex Industries maintains a robust balance sheet, evidenced by total reserves of ₹5,666 Cr against minimal borrowings of only ₹21 Cr. This positions the company favorably in terms of financial stability, with a debt-to-equity ratio of just 0.03, indicating a low reliance on external financing. The book value per share has increased to ₹98.60, reflecting the company’s underlying asset strength. The current ratio stands at 3.56, substantially above the typical sector range, suggesting strong short-term liquidity. However, the asset turnover ratio has declined to 0.57, indicating potential inefficiencies in utilizing assets to generate revenue. Financial ratios such as the price-to-book value (P/BV) at 1.83x indicate a fair valuation compared to the sector, which often sees P/BV ratios in the range of 2-3x, suggesting potential upside for investors should operational efficiencies improve.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Finolex Industries demonstrates a stable ownership structure, with promoters holding 52.47% of the shares. This strong promoter presence can instill confidence among investors regarding long-term strategic direction. Foreign institutional investors (FIIs) hold 5.93%, reflecting a cautious but present interest from international markets. Domestic institutional investors (DIIs) account for 12.11%, further indicating institutional support for the company. The public holding stands at 29.13%, showcasing a healthy retail investor base. While the number of shareholders has decreased from 2,48,095 in December 2022 to 2,45,505 in September 2025, the stability in promoter holdings and institutional investment suggests a robust foundation for future growth. However, the declining public shareholding could raise concerns about investor sentiment, particularly if not addressed through improved performance.
Outlook, Risks, and Final Insight
Looking ahead, Finolex Industries faces both opportunities and risks. The firm has the potential to leverage its strong balance sheet and low debt levels to invest in efficiency improvements and expand its market share. However, the decline in sales and profitability metrics poses significant risks. The fluctuating demand in the plastics sector could hinder future revenue growth, while rising raw material costs could further pressure margins. Additionally, the company’s relatively low ROE and ROCE highlight the need for enhanced operational efficiencies. As such, it is crucial for management to focus on cost control and innovation to drive growth. If these challenges are navigated effectively, Finolex could see a rebound in performance, but failure to address these issues may limit its competitive advantage in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Finolex Industries Ltd | 10,782 Cr. | 174 | 238/144 | 24.6 | 93.3 | 1.15 % | 8.77 % | 6.76 % | 2.00 |
| Industry Average | 10,782.00 Cr | 174.00 | 24.60 | 93.30 | 1.15% | 8.77% | 6.76% | 2.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 941 | 1,125 | 1,141 | 1,179 | 883 | 1,020 | 1,235 | 1,140 | 828 | 1,001 | 1,172 | 1,043 | 859 |
| Expenses | 1,084 | 1,033 | 924 | 1,027 | 780 | 900 | 1,026 | 934 | 818 | 918 | 1,001 | 950 | 729 |
| Operating Profit | -143 | 92 | 217 | 152 | 103 | 120 | 209 | 207 | 11 | 83 | 171 | 94 | 130 |
| OPM % | -15% | 8% | 19% | 13% | 12% | 12% | 17% | 18% | 1% | 8% | 15% | 9% | 15% |
| Other Income | 39 | 28 | 29 | 40 | 63 | 35 | 44 | 472 | 84 | 48 | 65 | 65 | 60 |
| Interest | 4 | 5 | 6 | 9 | 12 | 8 | 7 | 7 | 7 | 10 | 6 | 6 | 4 |
| Depreciation | 22 | 22 | 24 | 34 | 27 | 28 | 27 | 26 | 26 | 27 | 27 | 27 | 27 |
| Profit before tax | -129 | 92 | 216 | 149 | 126 | 120 | 219 | 646 | 62 | 95 | 203 | 126 | 158 |
| Tax % | -27% | 22% | 27% | 26% | 25% | 26% | 26% | 22% | 16% | 25% | 26% | 23% | 25% |
| Net Profit | -94 | 72 | 158 | 111 | 94 | 89 | 161 | 505 | 51 | 71 | 150 | 97 | 119 |
| EPS in Rs | -1.51 | 1.16 | 2.55 | 1.79 | 1.51 | 1.44 | 2.60 | 8.14 | 0.83 | 1.14 | 2.42 | 1.56 | 1.92 |
Last Updated: January 12, 2026, 9:46 am
Below is a detailed analysis of the quarterly data for Finolex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 859.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,043.00 Cr. (Jun 2025) to 859.00 Cr., marking a decrease of 184.00 Cr..
- For Expenses, as of Sep 2025, the value is 729.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 950.00 Cr. (Jun 2025) to 729.00 Cr., marking a decrease of 221.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Jun 2025) to 130.00 Cr., marking an increase of 36.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Jun 2025) to 15.00%, marking an increase of 6.00%.
- For Other Income, as of Sep 2025, the value is 60.00 Cr.. The value appears to be declining and may need further review. It has decreased from 65.00 Cr. (Jun 2025) to 60.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.00 Cr. (Jun 2025) to 4.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 27.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 158.00 Cr.. The value appears strong and on an upward trend. It has increased from 126.00 Cr. (Jun 2025) to 158.00 Cr., marking an increase of 32.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Jun 2025) to 25.00%, marking an increase of 2.00%.
- For Net Profit, as of Sep 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 97.00 Cr. (Jun 2025) to 119.00 Cr., marking an increase of 22.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.92. The value appears strong and on an upward trend. It has increased from 1.56 (Jun 2025) to 1.92, marking an increase of 0.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,453 | 2,476 | 2,482 | 2,602 | 2,738 | 3,091 | 2,985 | 3,462 | 4,647 | 4,397 | 4,317 | 4,142 | 4,075 |
| Expenses | 2,056 | 2,264 | 2,075 | 2,039 | 2,253 | 2,487 | 2,536 | 2,472 | 3,623 | 4,105 | 3,732 | 3,666 | 3,596 |
| Operating Profit | 397 | 212 | 407 | 563 | 484 | 604 | 448 | 990 | 1,025 | 293 | 585 | 476 | 478 |
| OPM % | 16% | 9% | 16% | 22% | 18% | 20% | 15% | 29% | 22% | 7% | 14% | 12% | 12% |
| Other Income | -27 | -2 | 62 | 24 | 25 | 14 | 30 | 72 | 458 | 121 | 181 | 665 | 237 |
| Interest | 66 | 70 | 45 | 15 | 10 | 12 | 11 | 7 | 14 | 27 | 36 | 30 | 26 |
| Depreciation | 62 | 59 | 51 | 55 | 61 | 70 | 74 | 78 | 83 | 89 | 116 | 107 | 108 |
| Profit before tax | 242 | 81 | 373 | 517 | 439 | 536 | 393 | 977 | 1,385 | 297 | 613 | 1,005 | 581 |
| Tax % | 30% | 41% | 32% | 32% | 32% | 35% | 18% | 25% | 24% | 20% | 26% | 23% | |
| Net Profit | 170 | 48 | 254 | 352 | 299 | 350 | 324 | 728 | 1,053 | 237 | 455 | 778 | 437 |
| EPS in Rs | 2.74 | 0.77 | 4.10 | 5.68 | 4.81 | 5.64 | 5.22 | 11.73 | 16.98 | 3.81 | 7.34 | 12.54 | 7.04 |
| Dividend Payout % | 51% | 52% | 49% | 41% | 42% | 35% | 38% | 34% | 24% | 39% | 34% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -71.76% | 429.17% | 38.58% | -15.06% | 17.06% | -7.43% | 124.69% | 44.64% | -77.49% | 91.98% | 70.99% |
| Change in YoY Net Profit Growth (%) | 0.00% | 500.93% | -390.58% | -53.64% | 32.11% | -24.49% | 132.12% | -80.05% | -122.14% | 169.48% | -20.99% |
Finolex Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 7% |
| 3 Years: | -4% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 4% |
| 3 Years: | -20% |
| TTM: | -29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | 12% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 7% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 4:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:15 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 |
| Reserves | 666 | 663 | 1,446 | 2,167 | 2,640 | 2,404 | 1,806 | 2,949 | 3,740 | 4,701 | 5,414 | 5,855 | 5,666 |
| Borrowings | 713 | 637 | 212 | 94 | 101 | 90 | 283 | 204 | 278 | 541 | 394 | 237 | 21 |
| Other Liabilities | 433 | 435 | 567 | 570 | 589 | 655 | 603 | 930 | 1,119 | 817 | 996 | 1,008 | 798 |
| Total Liabilities | 1,936 | 1,859 | 2,349 | 2,955 | 3,455 | 3,273 | 2,815 | 4,207 | 5,261 | 6,182 | 6,928 | 7,223 | 6,609 |
| Fixed Assets | 905 | 868 | 850 | 855 | 884 | 951 | 1,017 | 1,002 | 993 | 1,055 | 1,055 | 1,008 | 1,015 |
| CWIP | 32 | 10 | 7 | 22 | 90 | 90 | 7 | 8 | 9 | 44 | 19 | 73 | 41 |
| Investments | 221 | 180 | 817 | 1,222 | 1,555 | 1,303 | 580 | 1,592 | 2,633 | 3,850 | 4,456 | 4,751 | 4,239 |
| Other Assets | 777 | 801 | 675 | 856 | 925 | 929 | 1,211 | 1,604 | 1,625 | 1,234 | 1,398 | 1,391 | 1,314 |
| Total Assets | 1,936 | 1,859 | 2,349 | 2,955 | 3,455 | 3,273 | 2,815 | 4,207 | 5,261 | 6,182 | 6,928 | 7,223 | 6,609 |
Below is a detailed analysis of the balance sheet data for Finolex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 124.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 124.00 Cr..
- For Reserves, as of Sep 2025, the value is 5,666.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,855.00 Cr. (Mar 2025) to 5,666.00 Cr., marking a decrease of 189.00 Cr..
- For Borrowings, as of Sep 2025, the value is 21.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 237.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 216.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 798.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,008.00 Cr. (Mar 2025) to 798.00 Cr., marking a decrease of 210.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 6,609.00 Cr.. The value appears to be improving (decreasing). It has decreased from 7,223.00 Cr. (Mar 2025) to 6,609.00 Cr., marking a decrease of 614.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,015.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,008.00 Cr. (Mar 2025) to 1,015.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 32.00 Cr..
- For Investments, as of Sep 2025, the value is 4,239.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,751.00 Cr. (Mar 2025) to 4,239.00 Cr., marking a decrease of 512.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,314.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,391.00 Cr. (Mar 2025) to 1,314.00 Cr., marking a decrease of 77.00 Cr..
- For Total Assets, as of Sep 2025, the value is 6,609.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,223.00 Cr. (Mar 2025) to 6,609.00 Cr., marking a decrease of 614.00 Cr..
Notably, the Reserves (5,666.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -316.00 | -425.00 | 195.00 | 469.00 | 383.00 | 514.00 | 165.00 | 786.00 | -277.00 | -248.00 | 191.00 | 239.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 7 | 3 | 7 | 6 | 9 | 9 | 16 | 26 | 25 | 39 | 33 |
| Inventory Days | 112 | 113 | 100 | 128 | 128 | 120 | 164 | 176 | 132 | 81 | 99 | 108 |
| Days Payable | 25 | 40 | 55 | 52 | 52 | 55 | 44 | 84 | 60 | 35 | 39 | 61 |
| Cash Conversion Cycle | 93 | 80 | 48 | 83 | 81 | 74 | 129 | 108 | 98 | 71 | 98 | 80 |
| Working Capital Days | -14 | -6 | 0 | 28 | 32 | 33 | 39 | 22 | 17 | -6 | 13 | 20 |
| ROCE % | 23% | 11% | 24% | 25% | 17% | 21% | 16% | 36% | 27% | 6% | 10% | 9% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 34,595,699 | 1.7 | 618.33 | 34,595,699 | 2025-04-22 14:12:25 | 0% |
| Franklin India Small Cap Fund | 7,057,734 | 0.93 | 126.14 | N/A | N/A | N/A |
| HSBC Small Cap Fund | 5,734,257 | 0.63 | 102.49 | 5,984,579 | 2025-12-15 01:03:40 | -4.18% |
| ICICI Prudential Smallcap Fund | 3,200,000 | 0.68 | 57.19 | N/A | N/A | N/A |
| HDFC Retirement Savings Fund - Equity | 1,650,000 | 0.42 | 29.49 | N/A | N/A | N/A |
| Bandhan Multi Cap Fund | 1,500,000 | 0.93 | 26.81 | 1,299,000 | 2025-12-15 01:03:40 | 15.47% |
| Bandhan Value Fund | 1,299,000 | 0.22 | 23.22 | N/A | N/A | N/A |
| Templeton India Value Fund | 1,100,000 | 0.85 | 19.66 | N/A | N/A | N/A |
| ICICI Prudential Childrens Fund | 1,000,000 | 1.26 | 17.87 | N/A | N/A | N/A |
| HDFC Equity Savings Fund | 600,000 | 0.18 | 10.72 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | 12.94 | 7.66 | 4.04 | 16.94 | 11.89 |
| Diluted EPS (Rs.) | 12.94 | 7.66 | 4.04 | 16.94 | 11.89 |
| Cash EPS (Rs.) | 14.01 | 8.92 | 5.10 | 18.31 | 64.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 98.60 | 91.12 | 79.29 | 63.30 | 252.94 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 98.60 | 91.12 | 79.29 | 63.30 | 252.94 |
| Revenue From Operations / Share (Rs.) | 66.98 | 69.82 | 71.11 | 74.90 | 279.03 |
| PBDIT / Share (Rs.) | 11.68 | 12.37 | 6.69 | 17.82 | 85.48 |
| PBIT / Share (Rs.) | 9.96 | 10.49 | 5.24 | 16.48 | 79.22 |
| PBT / Share (Rs.) | 16.22 | 9.90 | 4.80 | 22.31 | 78.64 |
| Net Profit / Share (Rs.) | 12.29 | 7.04 | 3.66 | 16.97 | 58.15 |
| NP After MI And SOA / Share (Rs.) | 12.94 | 7.66 | 4.05 | 16.94 | 59.45 |
| PBDIT Margin (%) | 17.44 | 17.71 | 9.40 | 23.79 | 30.63 |
| PBIT Margin (%) | 14.86 | 15.02 | 7.37 | 22.00 | 28.39 |
| PBT Margin (%) | 24.21 | 14.18 | 6.75 | 29.79 | 28.18 |
| Net Profit Margin (%) | 18.34 | 10.08 | 5.14 | 22.65 | 20.83 |
| NP After MI And SOA Margin (%) | 19.31 | 10.96 | 5.70 | 22.62 | 21.30 |
| Return on Networth / Equity (%) | 13.12 | 8.40 | 5.11 | 26.76 | 23.50 |
| Return on Capital Employeed (%) | 9.61 | 10.89 | 6.29 | 24.66 | 29.27 |
| Return On Assets (%) | 10.83 | 6.71 | 3.98 | 19.66 | 17.18 |
| Total Debt / Equity (X) | 0.03 | 0.06 | 0.10 | 0.07 | 0.06 |
| Asset Turnover Ratio (%) | 0.57 | 0.64 | 0.75 | 0.97 | 0.97 |
| Current Ratio (X) | 3.56 | 2.90 | 2.55 | 2.54 | 2.12 |
| Quick Ratio (X) | 2.75 | 2.24 | 1.95 | 1.69 | 1.14 |
| Inventory Turnover Ratio (X) | 5.48 | 3.92 | 3.44 | 2.90 | 2.18 |
| Dividend Payout Ratio (NP) (%) | 19.32 | 19.58 | 98.99 | 23.60 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 17.05 | 15.73 | 73.01 | 21.87 | 0.00 |
| Earning Retention Ratio (%) | 80.68 | 80.42 | 1.01 | 76.40 | 0.00 |
| Cash Earning Retention Ratio (%) | 82.95 | 84.27 | 26.99 | 78.13 | 0.00 |
| Interest Coverage Ratio (X) | 24.37 | 20.98 | 15.18 | 78.49 | 145.92 |
| Interest Coverage Ratio (Post Tax) (X) | 12.57 | 12.94 | 9.32 | 49.03 | 100.26 |
| Enterprise Value (Cr.) | 11222.93 | 15601.90 | 11024.14 | 9802.33 | 7772.76 |
| EV / Net Operating Revenue (X) | 2.71 | 3.61 | 2.51 | 2.11 | 2.24 |
| EV / EBITDA (X) | 15.53 | 20.40 | 26.66 | 8.86 | 7.33 |
| MarketCap / Net Operating Revenue (X) | 2.69 | 3.53 | 2.40 | 2.07 | 2.28 |
| Retention Ratios (%) | 80.67 | 80.41 | 1.00 | 76.39 | 0.00 |
| Price / BV (X) | 1.83 | 2.71 | 2.15 | 2.45 | 2.52 |
| Price / Net Operating Revenue (X) | 2.69 | 3.53 | 2.40 | 2.07 | 2.28 |
| EarningsYield | 0.07 | 0.03 | 0.02 | 0.10 | 0.09 |
After reviewing the key financial ratios for Finolex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.01. This value is within the healthy range. It has increased from 8.92 (Mar 24) to 14.01, marking an increase of 5.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.60. It has increased from 91.12 (Mar 24) to 98.60, marking an increase of 7.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.60. It has increased from 91.12 (Mar 24) to 98.60, marking an increase of 7.48.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 66.98. It has decreased from 69.82 (Mar 24) to 66.98, marking a decrease of 2.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 11.68. This value is within the healthy range. It has decreased from 12.37 (Mar 24) to 11.68, marking a decrease of 0.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 9.96. This value is within the healthy range. It has decreased from 10.49 (Mar 24) to 9.96, marking a decrease of 0.53.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.22. This value is within the healthy range. It has increased from 9.90 (Mar 24) to 16.22, marking an increase of 6.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.29. This value is within the healthy range. It has increased from 7.04 (Mar 24) to 12.29, marking an increase of 5.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.44. This value is within the healthy range. It has decreased from 17.71 (Mar 24) to 17.44, marking a decrease of 0.27.
- For PBIT Margin (%), as of Mar 25, the value is 14.86. This value is within the healthy range. It has decreased from 15.02 (Mar 24) to 14.86, marking a decrease of 0.16.
- For PBT Margin (%), as of Mar 25, the value is 24.21. This value is within the healthy range. It has increased from 14.18 (Mar 24) to 24.21, marking an increase of 10.03.
- For Net Profit Margin (%), as of Mar 25, the value is 18.34. This value exceeds the healthy maximum of 10. It has increased from 10.08 (Mar 24) to 18.34, marking an increase of 8.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.31. This value is within the healthy range. It has increased from 10.96 (Mar 24) to 19.31, marking an increase of 8.35.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.12. This value is below the healthy minimum of 15. It has increased from 8.40 (Mar 24) to 13.12, marking an increase of 4.72.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.61. This value is below the healthy minimum of 10. It has decreased from 10.89 (Mar 24) to 9.61, marking a decrease of 1.28.
- For Return On Assets (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 10.83, marking an increase of 4.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.64 (Mar 24) to 0.57, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 2.90 (Mar 24) to 3.56, marking an increase of 0.66.
- For Quick Ratio (X), as of Mar 25, the value is 2.75. This value exceeds the healthy maximum of 2. It has increased from 2.24 (Mar 24) to 2.75, marking an increase of 0.51.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.48. This value is within the healthy range. It has increased from 3.92 (Mar 24) to 5.48, marking an increase of 1.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.32. This value is below the healthy minimum of 20. It has decreased from 19.58 (Mar 24) to 19.32, marking a decrease of 0.26.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 17.05. This value is below the healthy minimum of 20. It has increased from 15.73 (Mar 24) to 17.05, marking an increase of 1.32.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.68. This value exceeds the healthy maximum of 70. It has increased from 80.42 (Mar 24) to 80.68, marking an increase of 0.26.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 82.95. This value exceeds the healthy maximum of 70. It has decreased from 84.27 (Mar 24) to 82.95, marking a decrease of 1.32.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 24.37. This value is within the healthy range. It has increased from 20.98 (Mar 24) to 24.37, marking an increase of 3.39.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 12.57. This value is within the healthy range. It has decreased from 12.94 (Mar 24) to 12.57, marking a decrease of 0.37.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,222.93. It has decreased from 15,601.90 (Mar 24) to 11,222.93, marking a decrease of 4,378.97.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.71. This value is within the healthy range. It has decreased from 3.61 (Mar 24) to 2.71, marking a decrease of 0.90.
- For EV / EBITDA (X), as of Mar 25, the value is 15.53. This value exceeds the healthy maximum of 15. It has decreased from 20.40 (Mar 24) to 15.53, marking a decrease of 4.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.53 (Mar 24) to 2.69, marking a decrease of 0.84.
- For Retention Ratios (%), as of Mar 25, the value is 80.67. This value exceeds the healthy maximum of 70. It has increased from 80.41 (Mar 24) to 80.67, marking an increase of 0.26.
- For Price / BV (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.71 (Mar 24) to 1.83, marking a decrease of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.53 (Mar 24) to 2.69, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.07, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Finolex Industries Ltd:
- Net Profit Margin: 18.34%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.61% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.12% (Industry Average ROE: 6.76%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 12.57
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.6 (Industry average Stock P/E: 24.6)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.34%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | Gat No. 399, Village Urse, Pune District Maharashtra 410506 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prakash P Chhabria | Executive Chairman |
| Mr. Saurabh S Dhanorkar | Managing Director |
| Mr. Saumya Chakrabarti | Director - Technical |
| Mrs. Ritu P Chhabria | Non Exe.Non Ind.Director |
| Mrs. Kanchan U Chitale | Independent Director |
| Mr. Debabrata Sarkar | Independent Director |
| Mr. Vijay Bhatt | Independent Director |
| Mr. Aditya Sapru | Independent Director |
| Mr. Munesh Khanna | Independent Director |
| Mr. Pradeep Udhas | Independent Director |
| Mr. Rajesh Rathi | Independent Director |
FAQ
What is the intrinsic value of Finolex Industries Ltd?
Finolex Industries Ltd's intrinsic value (as of 25 January 2026) is ₹105.28 which is 39.49% lower the current market price of ₹174.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹10,782 Cr. market cap, FY2025-2026 high/low of ₹238/144, reserves of ₹5,666 Cr, and liabilities of ₹6,609 Cr.
What is the Market Cap of Finolex Industries Ltd?
The Market Cap of Finolex Industries Ltd is 10,782 Cr..
What is the current Stock Price of Finolex Industries Ltd as on 25 January 2026?
The current stock price of Finolex Industries Ltd as on 25 January 2026 is ₹174.
What is the High / Low of Finolex Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Finolex Industries Ltd stocks is ₹238/144.
What is the Stock P/E of Finolex Industries Ltd?
The Stock P/E of Finolex Industries Ltd is 24.6.
What is the Book Value of Finolex Industries Ltd?
The Book Value of Finolex Industries Ltd is 93.3.
What is the Dividend Yield of Finolex Industries Ltd?
The Dividend Yield of Finolex Industries Ltd is 1.15 %.
What is the ROCE of Finolex Industries Ltd?
The ROCE of Finolex Industries Ltd is 8.77 %.
What is the ROE of Finolex Industries Ltd?
The ROE of Finolex Industries Ltd is 6.76 %.
What is the Face Value of Finolex Industries Ltd?
The Face Value of Finolex Industries Ltd is 2.00.